Lo YH - Search Results

1

Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.

Zhao H, Lo YH, Ma L, Waltz SE, Gray JK, Hung MC, Wang SC. Zhao H, et al. Among authors: lo yh. Mol Cancer Ther. 2011 Jan;10(1):29-36. doi: 10.1158/1535-7163.MCT-10-0778. Mol Cancer Ther. 2011. PMID: 21220489 Free PMC article.

2

Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016).

Lo YH, Ho PC, Zhao H, Wang SC. Lo YH, et al. Anticancer Res. 2011 Mar;31(3):789-95. Anticancer Res. 2011. PMID: 21498698

3

Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer.

Zhao H, Ho PC, Lo YH, Espejo A, Bedford MT, Hung MC, Wang SC. Zhao H, et al. Among authors: lo yh. PLoS One. 2012;7(1):e29416. doi: 10.1371/journal.pone.0029416. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238610 Free PMC article.

4

Epidermal growth factor receptor protects proliferating cell nuclear antigen from cullin 4A protein-mediated proteolysis.

Lo YH, Ho PC, Wang SC. Lo YH, et al. J Biol Chem. 2012 Aug 3;287(32):27148-57. doi: 10.1074/jbc.M112.388843. Epub 2012 Jun 12. J Biol Chem. 2012. PMID: 22692198 Free PMC article.

5

Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.

Lo YH, Ho PC, Chen MS, Hugo E, Ben-Jonathan N, Wang SC. Lo YH, et al. Biochem Biophys Res Commun. 2013 Jan 4;430(1):43-8. doi: 10.1016/j.bbrc.2012.11.047. Epub 2012 Nov 28. Biochem Biophys Res Commun. 2013. PMID: 23201573 Free PMC article.

6

Overcoming resistance to fulvestrant (ICI182,780) by downregulating the c-ABL proto-oncogene in breast cancer.

Zhao H, Lo YH, Yu L, Wang SC. Zhao H, et al. Among authors: lo yh. Mol Carcinog. 2011 May;50(5):383-9. doi: 10.1002/mc.20721. Epub 2010 Dec 28. Mol Carcinog. 2011. PMID: 21480391

7

Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.

Chen MS, Lo YH, Chen X, Williams CS, Donnelly JM, Criss ZK 2nd, Patel S, Butkus JM, Dubrulle J, Finegold MJ, Shroyer NF. Chen MS, et al. Among authors: lo yh. Mol Cancer Res. 2019 Mar;17(3):697-708. doi: 10.1158/1541-7786.MCR-18-0666. Epub 2019 Jan 3. Mol Cancer Res. 2019. PMID: 30606770 Free PMC article.

8

SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.

Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ, Shroyer NF. Noah TK, et al. Among authors: lo yh. Gastroenterology. 2013 May;144(5):1012-1023.e6. doi: 10.1053/j.gastro.2013.01.043. Epub 2013 Feb 1. Gastroenterology. 2013. PMID: 23376423 Free PMC article.

9

CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities.

Han K, Pierce SE, Li A, Spees K, Anderson GR, Seoane JA, Lo YH, Dubreuil M, Olivas M, Kamber RA, Wainberg M, Kostyrko K, Kelly MR, Yousefi M, Simpkins SW, Yao D, Lee K, Kuo CJ, Jackson PK, Sweet-Cordero A, Kundaje A, Gentles AJ, Curtis C, Winslow MM, Bassik MC. Han K, et al. Among authors: lo yh. Nature. 2020 Apr;580(7801):136-141. doi: 10.1038/s41586-020-2099-x. Epub 2020 Mar 11. Nature. 2020. PMID: 32238925 Free PMC article.

10

Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration.

Gilbert S, Nivarthi H, Mayhew CN, Lo YH, Noah TK, Vallance J, Rülicke T, Müller M, Jegga AG, Tang W, Zhang D, Helmrath M, Shroyer N, Moriggl R, Han X. Gilbert S, et al. Among authors: lo yh. Stem Cell Reports. 2015 Feb 10;4(2):209-25. doi: 10.1016/j.stemcr.2014.12.004. Epub 2015 Jan 8. Stem Cell Reports. 2015. PMID: 25579133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters